Article 25 Jul 2016 Forget About Vermont!: Congress Passes GMO "Labeling" Legislation United States Healthcare
Article 04 Sep 2015 What's In A Name? That Which We Call A Biological Product… United States Healthcare
Article 13 Jan 2015 New FDA Draft Guidance On REMS And Bioequivalence Studies: Does New Procedure Secure ANDA Applicants The Right To Obtain Samples? United States Healthcare
Article 31 Dec 2014 Update: Sandoz And Celltrion Decline The Invitation To Dance: Biosimilars Challenge The Applicability Of The BPCIA’s Exchange Provisions Before Bringing Suit United States IP
Article 24 Mar 2014 FTC Targets Reporting Of Licensing Of Pharmaceutical Patents With Special Rules For Premerger Notification: What You Need To Know United States Healthcare
Article 08 Jan 2014 A Short-Lived Victory For Generic Manufacturers? – Part 2 United States Healthcare
Article 25 Nov 2013 No Avoiding BPCIA For Biosimilars: No Patent Declaratory Judgment Action Before Biosimilars Application Is Filed United States IP
Article 29 Oct 2013 FDA’s Draft Guidance For Industry On Pre-Launch Activities Importation Requests: Dead On Arrival? United States Healthcare
Article 01 Aug 2013 FDA's Draft Guidance For Industry On Pre-Launch Activities Importation Requests: Dead On Arrival? United States Healthcare